Silence Therapeutics Plc Stock Technical Analysis

SLN Stock  USD 6.60  0.15  2.33%   
As of the 13th of December 2024, Silence Therapeutics has the Coefficient Of Variation of (461.79), risk adjusted performance of (0.15), and Variance of 37.88. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Silence Therapeutics PLC, as well as the relationship between them.

Silence Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Silence, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Silence
  
Silence Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Silence Therapeutics Analyst Consensus

Target PriceAdvice# of Analysts
39.53Strong Buy6Odds
Silence Therapeutics PLC current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Silence analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Silence stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Silence Therapeutics PLC, talking to its executives and customers, or listening to Silence conference calls.
Silence Analyst Advice Details
Silence Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Silence Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Silence Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Silence Therapeutics PLC Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Silence Therapeutics PLC volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Silence Therapeutics PLC Trend Analysis

Use this graph to draw trend lines for Silence Therapeutics PLC. You can use it to identify possible trend reversals for Silence Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Silence Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Silence Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Silence Therapeutics PLC applied against its price change over selected period. The best fit line has a slop of   0.23  , which may imply that the returns on investment in Silence Therapeutics PLC will continue to fail. It has 122 observation points and a regression sum of squares at 2003.77, which is the sum of squared deviations for the predicted Silence Therapeutics price change compared to its average price change.

About Silence Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Silence Therapeutics PLC on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Silence Therapeutics PLC based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Silence Therapeutics PLC price pattern first instead of the macroeconomic environment surrounding Silence Therapeutics PLC. By analyzing Silence Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Silence Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Silence Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding249.52361.68270.9257.35
PTB Ratio61.3818.3929.7131.2

Silence Therapeutics December 13, 2024 Technical Indicators

Most technical analysis of Silence help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Silence from various momentum indicators to cycle indicators. When you analyze Silence charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Silence Therapeutics December 13, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Silence stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Silence Therapeutics PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Silence Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Silence Therapeutics Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Silence Therapeutics Plc Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silence Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Silence Therapeutics. If investors know Silence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Silence Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.76)
Revenue Per Share
0.429
Quarterly Revenue Growth
(0.93)
Return On Assets
(0.22)
Return On Equity
(0.64)
The market value of Silence Therapeutics PLC is measured differently than its book value, which is the value of Silence that is recorded on the company's balance sheet. Investors also form their own opinion of Silence Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Silence Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Silence Therapeutics' market value can be influenced by many factors that don't directly affect Silence Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Silence Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Silence Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Silence Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.